TABLE 2.
Variable | Systemic sclerosis average annual change % (95% CI) | Systemic sclerosis−pulmonary hypertension average annual change % (95% CI) |
Total | −3.0 (−3.3 to −2.7)# | 0.1 (−2.3 to 2.6)¶ |
Sex | ||
Male | −3.5 (−4.1 to −2.8) | −1.4 (−3.0 to 0.1) |
Female | −2.7 (−3.0 to −2.4) | 0.5 (−2.1 to 3.2) |
Race | ||
White | −2.9 (−3.3 to −2.5) | 0.1 (−2.6 to 2.9) |
Black | −3.6 (−4.7 to −2.5) | −0.4 (−3.1 to 2.4) |
Hispanic | −3.5 (−4.7 to −2.2) | −0.9 (−3.1 to 1.3) |
Race/sex | ||
White men | −3.4 (−4.2 to −2.5) | −1.5 (−3.6 to 0.6) |
Black men | −4.1 (−6.3 to −1.9) | −1.2 (−5.6 to 3.4) |
Hispanic men | −4.1 (−6.9 to −1.1) | −1.5 (−12.2 to 10.3) |
White women | −2.5 (−2.9 to −2.1) | 0.7 (−2.0 to 3.4) |
Black women | −3.4 (−4.9 to −1.9) | −0.2 (−3.3 to 3.0) |
Hispanic women | −3.2 (−4.3 to −2.0) | −0.9 (−3.0 to 1.1) |
Region | ||
Northeast | −1.9 (−3.5 to −0.3) | −0.2 (−3.6 to 3.2) |
South | −4.2 (−4.9 to −3.5) | −1.0 (−3.4 to 1.3) |
Midwest | −2.8 (−3.9 to −1.6) | 1.0 (−1.8 to 3.9) |
West | −2.6 (−3.9 to −1.2) | −0.9 (−3.4 to 1.7) |
Age-groups years | ||
<35 | −0.8 (−3.4 to 1.8) | −1.4 (−7.1 to 4.7) |
35–54 | −3.5 (−4.2 to −2.9) | −1.7 (−4.6 to 1.4) |
55–74 | −3.7 (−4.2 to −3.3) | −1.2 (−2.7 to 0.3) |
≥75 | −1.1 (−2.7 to 0.6) | 3.6 (0.9 to 6.3) |
Contributing causes of death | ||
Respiratory | ||
Interstitial lung disease | 1.2 (−0.2 to 2.6) | 6.0 (2.0 to 10.2) |
COPD | −1.7 (−3.4 to 0) | 2.5 (−2.4 to 7.7) |
Pulmonary embolism | −0.2 (−2.9 to 2.6) | −1.5 (−5.5 to 2.7) |
Cardiovascular | ||
Ischaemic heart disease | −4.9 (−5.7 to −4.1) | 0.2 (−2.9 to 3.4) |
Cardiomyopathy | −1.7 (−2.7 to −0.8) | 2.7 (1.4 to 4.1) |
Hypertension | −2.2 (−3.3 to −1.2) | 3.1 (0.6 to 5.7) |
Valvular heart disease | −2.8 (−5.8 to 0.3) | 3.6 (−1.9 to 9.4) |
COPD: chronic obstructive pulmonary disease. #: no joinpoint identified.; ¶: one joinpoint identified at 2008: 2003–2008, APC 5.2% (95% CI −0.8 to 11.5); 2008–2016, APC −3.0% (−5.6 to −0.2%).